These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26377065)

  • 1. Pancytopenia in a patient with cystinosis secondary to myelosuppression from cystine crystal deposition: a case report.
    Lyou Y; Zhao X; Nangia CS
    J Med Case Rep; 2015 Sep; 9():205. PubMed ID: 26377065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematological manifestations of nephropathic cystinosis.
    Emadi A; Burns KH; Confer B; Borowitz MJ; Streiff MB
    Acta Haematol; 2008; 119(3):169-72. PubMed ID: 18493119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-cut diagnostic tool in cystinosis: Bone marrow aspiration.
    Sürmeli Döven S; Delibaş A; Kayacan UR; Ünal S
    Pediatr Int; 2017 Nov; 59(11):1178-1182. PubMed ID: 28871612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term cysteamine treatment in patients with cystinosis.
    Ariceta G; Giordano V; Santos F
    Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
    Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cystinosis : Diagnosis, cystine-depleting therapy, and transition].
    Kaufeld J; Weber LT; Kurschat C; Canaan-Kuehl S; Brand E; Oh J; Pape L
    Internist (Berl); 2018 Aug; 59(8):861-867. PubMed ID: 29671012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cystinosis: an infrequent cause of distal myopathy].
    Rodríguez-Gómez FJ; López-Domínguez JM; Borrero-Martín JJ; Rodríguez-Gómez E; Chinchón-Lara I; Pujol-De la Llave E
    Rev Neurol; 2005 Feb 1-15; 40(3):156-8. PubMed ID: 15750900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
    Nesterova G; Williams C; Bernardini I; Gahl WA
    Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate cystinosis: a case report of 10-year treatment with cysteamine.
    Kawamura M; Katagiri D; Yamamoto Y; Shimada K; Higashi S; Otani M; Uesugi N; Takano H; Shimizu Y; Okamura T
    BMC Nephrol; 2024 Aug; 25(1):275. PubMed ID: 39192178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephropathic cystinosis presenting with uveitis: Report of a "Can't See, Can't Pee" situation.
    Matthai SM; Jacob S; Bindra MS; David VG; Varughese S
    Indian J Pathol Microbiol; 2019; 62(3):457-460. PubMed ID: 31361240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystinosis: a review.
    Elmonem MA; Veys KR; Soliman NA; van Dyck M; van den Heuvel LP; Levtchenko E
    Orphanet J Rare Dis; 2016 Apr; 11():47. PubMed ID: 27102039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystinosis: clinical presentation, pathogenesis and treatment.
    Ivanova E; De Leo MG; De Matteis MA; Levtchenko E
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():176-84. PubMed ID: 25345100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephropatic cystinosis: report of one case].
    Krall P; Nualart D; Grandy J
    Rev Med Chil; 2018 Jan; 146(1):111-115. PubMed ID: 29806685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystinosis in adults: A systemic disease].
    Servais A; Goizet C; Bertholet-Thomas A; Decramer S; Llanas B; Choukroun G; Novo R
    Nephrol Ther; 2015 Jun; 11(3):152-9. PubMed ID: 25769364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular treatment of cystinosis with eye drop containing cysteamine].
    Csorba A; Maka E; Szabó A; Kelen K; Reusz G; Nagy ZZ
    Orv Hetil; 2022 May; 163(21):846-852. PubMed ID: 35598215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
    Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
    Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrarenal complications of cystinosis.
    Topaloglu R
    Pediatr Nephrol; 2024 Aug; 39(8):2283-2292. PubMed ID: 38127152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological complications of cystinosis.
    Cornet E; Repesse Y
    Eur J Haematol; 2015 Feb; 94(2):187. PubMed ID: 24684142
    [No Abstract]   [Full Text] [Related]  

  • 19. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.
    Gahl WA; Kuehl EM; Iwata F; Lindblad A; Kaiser-Kupfer MI
    Mol Genet Metab; 2000; 71(1-2):100-20. PubMed ID: 11001803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of topical cysteamine in nephropathic cystinosis.
    Al-Hemidan A; Shoughy SS; Kozak I; Tabbara KF
    Br J Ophthalmol; 2017 Sep; 101(9):1234-1237. PubMed ID: 28057644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.